Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Launched by SCRIPPS WHITTIER DIABETES INSTITUTE · Feb 28, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at ways to improve diabetes education for people with type 2 diabetes by adding a continuous glucose monitoring (CGM) device to a text messaging program. The goal is to see if using this technology can help patients manage their blood sugar levels better over the course of six months. The study will focus on participants who do not use insulin and will compare how well those who receive the CGM and education program do versus those who do not.

To be eligible for the trial, participants must be diagnosed with type 2 diabetes, not be using insulin, and not currently have a CGM device. They should also speak English, Spanish, or Arabic, have an A1c level (which measures blood sugar control) between 7.5% and 12.0%, and have a cellphone that can send and receive text messages. It’s important to note that the trial is not yet recruiting participants, so please keep an eye out for updates if you think you might be interested in joining!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with type 2 diabetes
• • Are not currently using a CGM
• • Are not using insulin therapies
• • Speak English, Spanish or Arabic
• • Have A1c between 7.5% and 12.0% in last 90 days
• • Have a cellphone that can receive/send text messages and counts steps
• Exclusion Criteria:
• • Are using insulin therapies
• • Are pregnant
• • Are currently using a CGM
• • Are currently participating in another diabetes-related study